TY - JOUR
T1 - Low-dose morphine reduces pain perception and blood pressure, but not muscle sympathetic outflow, responses during the cold pressor test
AU - Watso, s. Joseph C.
AU - Belval, Luke N.
AU - Cimino, Frank A.
AU - Orth, Bonnie D.
AU - Hendrix, Joseph M.
AU - Huang, Mu
AU - Johnson, Elias
AU - Foster, Josh
AU - Hinojosa-Laborde, Carmen
AU - Crandall, Craig G.
N1 - Funding Information:
This research was supported by Department of Defense-U.S. Army Grant W81XWH1820012 (to C.G.C.); American Physiology Society Postdoctoral Fellowship (to J.C.W.); and National Heart, Lung, and Blood Institute Grants F32HL154559 (to J.C.W.) and F32HL154565 (to L.N.B.).
Publisher Copyright:
© 2022 American Physiological Society. All rights reserved.
PY - 2022/7
Y1 - 2022/7
N2 - Our knowledge about how low-dose (analgesic) morphine affects autonomic cardiovascular regulation is primarily limited to animal experiments. Notably, it is unknown if low-dose morphine affects human autonomic cardiovascular responses during painful stimuli in conscious humans. Therefore, we tested the hypothesis that low-dose morphine reduces perceived pain and subsequent sympathetic and cardiovascular responses in humans during an experimental noxious stimulus. Twenty-nine participants (14 females/15 males; 29 ± 6 yr; 26 ± 4 kg m_2, means ± SD) completed this randomized, crossover, placebo-controlled trial during two laboratory visits. During each visit, participants completed a cold pressor test (CPT; hand in ∼0.4°C ice bath for 2 min) before and ∼35 min after drug/placebo administration (5 mg iv morphine or saline). We compared pain perception (100 mm visual analog scale), muscle sympathetic nerve activity (MSNA; microneurography; 14 paired recordings), and beat-to-beat blood pressure (BP; photoplethysmography) between trials (at both pre- and postdrug/placebo time points) using paired, two-tailed t tests. Before drug/placebo infusion, perceived pain (P = 0.92), DMSNA burst frequency (n = 14, P = 0.21), and Dmean BP (P = 0.39) during the CPT were not different between trials. After the drug/placebo infusion, morphine versus placebo attenuated perceived pain (morphine: 43 ± 20 vs. placebo: 57 ± 24 mm, P < 0.001) and Dmean BP (morphine: 10 ± 7 vs. placebo: 13 ± 8 mmHg, P = 0.003), but not DMSNA burst frequency (morphine: 10 ± 11 vs. placebo: 13 ± 11 bursts min_1, P = 0.12), during the CPT. Reductions in pain perception and Dmean BP were only weakly related (r = 0.34, P = 0.07; postmorphine CPT minus postplacebo CPT). These data provide valuable information regarding how low-dose morphine affects autonomic cardiovascular responses during an experimental painful stimulus.
AB - Our knowledge about how low-dose (analgesic) morphine affects autonomic cardiovascular regulation is primarily limited to animal experiments. Notably, it is unknown if low-dose morphine affects human autonomic cardiovascular responses during painful stimuli in conscious humans. Therefore, we tested the hypothesis that low-dose morphine reduces perceived pain and subsequent sympathetic and cardiovascular responses in humans during an experimental noxious stimulus. Twenty-nine participants (14 females/15 males; 29 ± 6 yr; 26 ± 4 kg m_2, means ± SD) completed this randomized, crossover, placebo-controlled trial during two laboratory visits. During each visit, participants completed a cold pressor test (CPT; hand in ∼0.4°C ice bath for 2 min) before and ∼35 min after drug/placebo administration (5 mg iv morphine or saline). We compared pain perception (100 mm visual analog scale), muscle sympathetic nerve activity (MSNA; microneurography; 14 paired recordings), and beat-to-beat blood pressure (BP; photoplethysmography) between trials (at both pre- and postdrug/placebo time points) using paired, two-tailed t tests. Before drug/placebo infusion, perceived pain (P = 0.92), DMSNA burst frequency (n = 14, P = 0.21), and Dmean BP (P = 0.39) during the CPT were not different between trials. After the drug/placebo infusion, morphine versus placebo attenuated perceived pain (morphine: 43 ± 20 vs. placebo: 57 ± 24 mm, P < 0.001) and Dmean BP (morphine: 10 ± 7 vs. placebo: 13 ± 8 mmHg, P = 0.003), but not DMSNA burst frequency (morphine: 10 ± 11 vs. placebo: 13 ± 11 bursts min_1, P = 0.12), during the CPT. Reductions in pain perception and Dmean BP were only weakly related (r = 0.34, P = 0.07; postmorphine CPT minus postplacebo CPT). These data provide valuable information regarding how low-dose morphine affects autonomic cardiovascular responses during an experimental painful stimulus.
KW - algometry
KW - cerebral tissue
KW - opioids
KW - respiration
KW - sympathoexcitatory
UR - http://www.scopus.com/inward/record.url?scp=85134360968&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134360968&partnerID=8YFLogxK
U2 - 10.1152/ajpheart.00092.2022
DO - 10.1152/ajpheart.00092.2022
M3 - Article
C2 - 35714174
AN - SCOPUS:85134360968
SN - 0363-6135
VL - 323
SP - H223-H234
JO - American Journal of Physiology - Heart and Circulatory Physiology
JF - American Journal of Physiology - Heart and Circulatory Physiology
IS - 1
ER -